Annalisa Jenkins
CIK 1639481 · President and CEO · last filed 2026-04-02
Annalisa Jenkins is a President and CEO who has filed 36 SEC Form 4 insider transactions across 8 companies since 2015. The most recent filing, for SKYE, was dated Apr 2, 2026. Across all open-market trades the lifetime net is −$42.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $381.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$381.6K
8
36
-$42.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SKYE | Director | — | $0.61 | — | $0 | 4 | 2026-04-02 |
| MREO | Director | — | $0.31 | — | $0 | 3 | 2026-02-27 |
| CMPS | Director | 19,480 | $10.85 | $211.4K | -$42.2K | 11 | 2025-06-13 |
| Tectonic Therapeutic, Inc. (AVRO) Delisted | Director | — | $16.80 | — | $0 | 5 | 2023-06-08 |
| Serina Therapeutics, Inc. (AGE) Delisted | Director | — | $11.10 | — | $0 | 2 | 2021-06-23 |
| ARDX | Director | 33,471 | $5.08 | $170.2K | $0 | 5 | 2019-06-17 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | President and CEO | — | — | — | $0 | 4 | 2017-11-07 |
| ONCOSEC MEDICAL Inc (ONCS) Delisted | Director | — | $0.28 | — | $0 | 1 | 2017-09-05 |
Recent Filings
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-02 | SKYE | Grant (A) | — | $0 | EDGAR |
| 2026-02-27 | MREO | Grant (A) | — | $0 | EDGAR |
| 2026-02-09 | SKYE | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | CMPS | Grant (A) | — | $0 | EDGAR |
| 2025-02-26 | SKYE | Grant (A) | — | $0 | EDGAR |
| 2025-02-06 | MREO | Grant (A) | — | $0 | EDGAR |
| 2024-10-30 | SKYE | Grant (A) | — | $0 | EDGAR |
| 2024-08-05 | CMPS | Tax (F) | −161 | -$1.1K | EDGAR |
| 2024-05-13 | CMPS | Grant (A) | — | $0 | EDGAR |
| 2024-05-03 | CMPS | Tax (F) | −211 | -$1.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.